BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 15200509)

  • 21. Clinical, molecular, and cellular immunologic findings in patients with SP110-associated veno-occlusive disease with immunodeficiency syndrome.
    Cliffe ST; Bloch DB; Suryani S; Kamsteeg EJ; Avery DT; Palendira U; Church JA; Wainstein BK; Trizzino A; Lefranc G; Akatcherian C; Megarbané A; Gilissen C; Moshous D; Reichenbach J; Misbah S; Salzer U; Abinun M; Ong PY; Stepensky P; Ruga E; Ziegler JB; Wong M; Tangye SG; Lindeman R; Buckley MF; Roscioli T
    J Allergy Clin Immunol; 2012 Sep; 130(3):735-742.e6. PubMed ID: 22621957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estimate of de novo mutation frequency in probands with PTEN hamartoma tumor syndrome.
    Mester J; Eng C
    Genet Med; 2012 Sep; 14(9):819-22. PubMed ID: 22595938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Allelic and phenotypic heterogeneity in 49 Italian patients with the muscle form of CPT-II deficiency.
    Fanin M; Anichini A; Cassandrini D; Fiorillo C; Scapolan S; Minetti C; Cassanello M; Donati MA; Siciliano G; D'Amico A; Lilliu F; Bruno C; Angelini C
    Clin Genet; 2012 Sep; 82(3):232-9. PubMed ID: 21913903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutations in NOTCH2 cause Hajdu-Cheney syndrome, a disorder of severe and progressive bone loss.
    Simpson MA; Irving MD; Asilmaz E; Gray MJ; Dafou D; Elmslie FV; Mansour S; Holder SE; Brain CE; Burton BK; Kim KH; Pauli RM; Aftimos S; Stewart H; Kim CA; Holder-Espinasse M; Robertson SP; Drake WM; Trembath RC
    Nat Genet; 2011 Mar; 43(4):303-5. PubMed ID: 21378985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel homozygous missense mutation (c.610G>A, p.Gly204Ser) in the WNT7A gene causes tetra-amelia in two Saudi families.
    Eyaid W; Al-Qattan MM; Al Abdulkareem I; Fetaini N; Al Balwi M
    Am J Med Genet A; 2011 Mar; 155A(3):599-604. PubMed ID: 21344627
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carnitine palmitoyl transferase II polymorphism is associated with multiple syndromes of acute encephalopathy with various infectious diseases.
    Shinohara M; Saitoh M; Takanashi J; Yamanouchi H; Kubota M; Goto T; Kikuchi M; Shiihara T; Yamanaka G; Mizuguchi M
    Brain Dev; 2011 Jun; 33(6):512-7. PubMed ID: 20934285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genotype-phenotype correlations in a large series of patients with muscle type CPT II deficiency.
    Anichini A; Fanin M; Vianey-Saban C; Cassandrini D; Fiorillo C; Bruno C; Angelini C
    Neurol Res; 2011 Jan; 33(1):24-32. PubMed ID: 20810031
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peutz-Jeghers syndrome: a systematic review and recommendations for management.
    Beggs AD; Latchford AR; Vasen HF; Moslein G; Alonso A; Aretz S; Bertario L; Blanco I; Bülow S; Burn J; Capella G; Colas C; Friedl W; Møller P; Hes FJ; Järvinen H; Mecklin JP; Nagengast FM; Parc Y; Phillips RK; Hyer W; Ponz de Leon M; Renkonen-Sinisalo L; Sampson JR; Stormorken A; Tejpar S; Thomas HJ; Wijnen JT; Clark SK; Hodgson SV
    Gut; 2010 Jul; 59(7):975-86. PubMed ID: 20581245
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comprehensive genotype-phenotype analysis in 230 patients with tetralogy of Fallot.
    Rauch R; Hofbeck M; Zweier C; Koch A; Zink S; Trautmann U; Hoyer J; Kaulitz R; Singer H; Rauch A
    J Med Genet; 2010 May; 47(5):321-31. PubMed ID: 19948535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. De novo copy number variants identify new genes and loci in isolated sporadic tetralogy of Fallot.
    Greenway SC; Pereira AC; Lin JC; DePalma SR; Israel SJ; Mesquita SM; Ergul E; Conta JH; Korn JM; McCarroll SA; Gorham JM; Gabriel S; Altshuler DM; Quintanilla-Dieck Mde L; Artunduaga MA; Eavey RD; Plenge RM; Shadick NA; Weinblatt ME; De Jager PL; Hafler DA; Breitbart RE; Seidman JG; Seidman CE
    Nat Genet; 2009 Aug; 41(8):931-5. PubMed ID: 19597493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Somatic LKB1 mutations promote cervical cancer progression.
    Wingo SN; Gallardo TD; Akbay EA; Liang MC; Contreras CM; Boren T; Shimamura T; Miller DS; Sharpless NE; Bardeesy N; Kwiatkowski DJ; Schorge JO; Wong KK; Castrillon DH
    PLoS One; 2009; 4(4):e5137. PubMed ID: 19340305
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of 23 TGFBR2 and 6 TGFBR1 gene mutations and genotype-phenotype investigations in 457 patients with Marfan syndrome type I and II, Loeys-Dietz syndrome and related disorders.
    Stheneur C; Collod-Béroud G; Faivre L; Gouya L; Sultan G; Le Parc JM; Moura B; Attias D; Muti C; Sznajder M; Claustres M; Junien C; Baumann C; Cormier-Daire V; Rio M; Lyonnet S; Plauchu H; Lacombe D; Chevallier B; Jondeau G; Boileau C
    Hum Mutat; 2008 Nov; 29(11):E284-95. PubMed ID: 18781618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CPT2 gene mutations resulting in lethal neonatal or severe infantile carnitine palmitoyltransferase II deficiency.
    Isackson PJ; Bennett MJ; Lichter-Konecki U; Willis M; Nyhan WL; Sutton VR; Tein I; Vladutiu GD
    Mol Genet Metab; 2008 Aug; 94(4):422-427. PubMed ID: 18550408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutations of carnitine palmitoyltransferase II (CPT II) in Japanese patients with CPT II deficiency.
    Yasuno T; Kaneoka H; Tokuyasu T; Aoki J; Yoshida S; Takayanagi M; Ohtake A; Kanazawa M; Ogawa A; Tojo K; Saito T
    Clin Genet; 2008 May; 73(5):496-501. PubMed ID: 18363739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LKB1 gene mutations in Japanese lung cancer patients.
    Onozato R; Kosaka T; Achiwa H; Kuwano H; Takahashi T; Yatabe Y; Mitsudomi T
    Cancer Sci; 2007 Nov; 98(11):1747-51. PubMed ID: 17711506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Are interrupted SCA2 CAG repeat expansions responsible for parkinsonism?
    Charles P; Camuzat A; Benammar N; Sellal F; Destée A; Bonnet AM; Lesage S; Le Ber I; Stevanin G; Dürr A; Brice A;
    Neurology; 2007 Nov; 69(21):1970-5. PubMed ID: 17568014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular and clinical characteristics in 46 families affected with Peutz-Jeghers syndrome.
    Mehenni H; Resta N; Guanti G; Mota-Vieira L; Lerner A; Peyman M; Chong KA; Aissa L; Ince A; Cosme A; Costanza MC; Rossier C; Radhakrishna U; Burt RW; Picard D
    Dig Dis Sci; 2007 Aug; 52(8):1924-33. PubMed ID: 17404884
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of 16 new disease-causing mutations in the CPT2 gene resulting in carnitine palmitoyltransferase II deficiency.
    Isackson PJ; Bennett MJ; Vladutiu GD
    Mol Genet Metab; 2006 Dec; 89(4):323-31. PubMed ID: 16996287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NOTCH2 mutations cause Alagille syndrome, a heterogeneous disorder of the notch signaling pathway.
    McDaniell R; Warthen DM; Sanchez-Lara PA; Pai A; Krantz ID; Piccoli DA; Spinner NB
    Am J Hum Genet; 2006 Jul; 79(1):169-73. PubMed ID: 16773578
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frequency and spectrum of cancers in the Peutz-Jeghers syndrome.
    Hearle N; Schumacher V; Menko FH; Olschwang S; Boardman LA; Gille JJ; Keller JJ; Westerman AM; Scott RJ; Lim W; Trimbath JD; Giardiello FM; Gruber SB; Offerhaus GJ; de Rooij FW; Wilson JH; Hansmann A; Möslein G; Royer-Pokora B; Vogel T; Phillips RK; Spigelman AD; Houlston RS
    Clin Cancer Res; 2006 May; 12(10):3209-15. PubMed ID: 16707622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.